Reports on insertional bgenotoxicityQ in patients have created intense interest in characterizing retroviral vector integrations on the genomic level. The retroviral vector SF91m3 was used for transduction of human peripheral blood progenitor cells (PBPC). These PBPC were transplanted into nonobese diabetic/severe combined immunodeficient mice. A total of 186 retroviral vector integration sites were isolated by ligation-mediated PCR from chimeric mouse bone marrow of five PBPC donors, sequenced, and blasted against the human genome. Preferred integration near the transcription start regions, within CpG islands, and within Alu regions was observed. Detailed analysis of targeted RefSeq genes showed a favored integration within the first intron. Integrations were most common in genes coding for signaling proteins, transcription factors, and kinases. In all genes targeted independently multiple times the respective orientation of the provirus within the gene was identical, indicating integration hot spot regions and similar steric determinants for integration sites. Possible explanations for these findings could be nonrandom vector integration, clonal selection due to gene expression interference, or engraftment issues related to gene insertion in signaling and cell cycle genes. The low frequency of integrations in exons may be reassuring as to the safety of retroviral gene therapy with normal human PBPC.
INTRODUCTION
Retroviral vectors are used as gene transfer vehicles in the majority of gene therapy protocols. They are distinguished from other viruses by two characteristic steps in their life cycle; one is the reverse transcription, which results in the formation of a double-stranded DNA copy of the viral RNA genome, and the other is the ability to integrate into the host genome by covalent attachment of the viral DNA to host cell DNA [1] [2] [3] . Such integrations pose a risk of disrupting genes or causing gene dysregulation.
Integration of retroviral sequences of wild type near proto-oncogenes has long been known to be capable of activating their expression, contributing to tumorigenesis in animal models [4] . Leukemogenic disease genes have been identified by cloning of common virus integration sites. This approach has proven to be a sensitive tool to identify novel proto-oncogenes as well as tumor-suppressor genes. In fact, several genes located near chromosomal breakpoints or otherwise aberrantly expressed in human hematopoietic malignancies have been identified through retroviral insertional mutagenesis in murine leukemias or lymphomas [5] , e.g., Evi1 [6, 7] , Evi2 (NF1) [8] [9] [10] , Evi6 (Hoxa9) [11, 12] , Bcl1 (cyclin D1) [13, 14] , and N-myc [15, 16] .
While for those interested in cancer research insertional mutagenesis is a tool to identify proto-oncogenes, it turned out that it represents a serious problem for those using retroviral vectors in clinical studies for medical applications. In the corrective gene therapy trial for Xchromosomal severe combined immunodeficiency (SCID-X1) [17] integration of the retroviral vector in the LMO2 proto-oncogene resulted in insertional mutagenesis and development of T cell leukemia in two children [18] [19] [20] . In the mouse model, leukemia developed as a consequence of the aberrant expression of the Evi1 protooncogene caused by a nearby integrated proviral genome [21] .
These results show the necessity of exploration of retroviral vector integration in cells used for clinical gene therapy application.
For cell lines an association of retroviral vector integration sites with transcriptionally active regions has been shown [22, 23] . Additionally it has been shown before that integrations occurred with significantly increased frequency into chromosomes 17 and 19 and also into specific regions of chromosomes 6, 13, and 16 when peripheral blood progenitor cells were transduced with the retroviral SF91m3 vector [24] . Here we analyzed for the first time the distribution of integration sites of retroviral vectors within genes and subgenomic regions of human hematopoietic cells repopulating the bone marrow of nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice (SCID repopulating cells, or SRC).
RESULTS
Our aim was to analyze the genomic distribution of integration sites of retroviral vectors within the DNA of human hematopoietic cells repopulating the bone marrow of NOD/SCID mice. We infected peripheral blood progenitor cells with the SF91m3 vector, which is based on the Friend mink cell focus-forming/murine embryonic stem-cell virus [25] . We transplanted transduced cells into NOD/SCID mice and after 6-8 weeks analyzed the cells recovered from the bone marrow. While the range of human CD45 + cells was between 3.5 and 43%, the amount of the transduced cells was 7-41%. We subjected the genomic DNA isolated from each sample to ligationmediated PCR (LM-PCR) as described before [24] and then cloned and sequenced the PCR products resulting from the LM-PCR.
Detection and Genomic Analysis of Retroviral Integration Sites
We sequenced a total of 207 integrations that met the validity criteria, i.e., detection of the sequence of the corresponding LTR on one end of the PCR product and the adapter sequence on the other end. For 156 of 207 integrations chromosomal mapping was published before [24] . Now, we have identified 51 additional integrations (n = 207) of two additional donors (n = 5). Of these 207 integrations we performed further detailed chromosomal analysis ( Fig. 1 ) and gene analysis and describe the results here. All 207 integrations originated from SF91m3 vector transductions. Of those, 186 integrations could unambiguously be matched with human DNA database sequences (identity N97%), reaffirming specificity of the LM-PCR method, while no matches to the human genome were found in 21 integrations.
One hundred forty-one of these 186 integrations landed within a 100-kb region up-and downstream of transcription start sites from genes ( Fig. 2) , while 45 integrations were not located within these regions. Integration analysis up-and downstream of targeted genes is necessary as recent data show that upstream integration can also be mutagenic [21, 26] and is a frequent form of oncogene activation by replicating MLV [27] . Of all mapped integrations 8.9% landed within a 5-kb region upstream of the transcription start site and 10.5% within 5 kb downstream, exceeding the 2.1% values calculated from the computer simulation of 10,000 random integrations described by Wu and colleagues (Table 1 ) [23] . CpG islands [28] have traditionally been defined as 200-bp regions of DNA with a G + C content over 50% and an observed/expected CpG ratio of 0.6 or more. Antequera and Bird proposed that CpG islands are associated with promoters that are transcriptionally active at totipotent stages of development and FIG. 1. Schematic distribution of retroviral vector integrations into chromosomes showing the RISCscore (retroviral insertion estimate into chromosome). For example, 15 and 13 integrations resulting from all five donors were found on chromosome 17 and chromosome 19, respectively, while 5 and 3 were expected when chromosome size and finished human genome sequences entered into the database (EMBL genome monitoring table, http:// www.ebi.ac.uk/genomes/mot/) taken into account. These differences are highly significant as evidenced by (oi À ei)) 2 /ei values (oi b ei Y RISC score Â (À1)) of 20 and 24, respectively (cutoff N3). In the case of nonpreferential integration a RISC score of 0 would be expected.
can also act as origins of DNA replication [29] . On the basis of these results we analyzed the integration sites in relation to their distance from the next CpG island up-or downstream. Thirty-five percent of the integrations occurred upstream and 41% downstream of the corresponding CpG island. It turned out that there is preferred integration near CpG islands i.e., 21% of the integrations occurred within F5 kb of the CpG island.
Additionally, we analyzed whether there is an increased integration near the Alu sequences that occur in the human genome. A detailed analysis of the draft sequence of the human genome has shown, of more than 1 million copies, Alu elements are the most abundant short interspersed elements (SINEs), which makes them the most abundant of all mobile elements in the human genome [30] . The Alu sequences account for 10% of human DNA alone and are ubiquitously dispersed throughout the genome but highly overrepresented in gene-rich regions of human DNA [31] . Additionally, it has been shown by Landers and colleagues that SINEs accumulate in GC-rich DNA regions [30, 32] . Analyzing our integration data we found that 37% of all mapped integrations landed in Alu sequences. The number of integrations analyzed (n = 186) was not sufficient to do a multivariate analysis of whether the increased integration frequency in the transcription start regions and Alu regions and the proximity to CpG islands are independent.
We further analyzed those integration sites that landed between the transcriptional start and stop boundaries of one of the 20471 human RefSeq genes (freeze 5, February 2004) [33] with respect to their exact integration sites (exon/intron). Our data showed that 40% (75/186) of SF91m3 integrations in human repopulating cells landed in RefSeq genes. All found retroviral insertions into RefSeqs are listed in Table 2 . These results are in line with the results recently published by Wu and colleagues (Table 1 ) [23] showing that 34% of integrations for MLV and 58% of integrations for HIV landed in RefSeq genes; both results were generated on cell lines. The results of integrations in RefSeq genes shown here are significantly different from the computer-simulated random data set generated by the same group showing that of 10,000 simulated integrations only 22% landed in RefSeq genes. The retroviral integrations analyzed here were obtained with the SF91m3 hybrid vector [34] , while Wu et al. [23] used the PCLnZ vector [35] , which combines the human CMV enhancer-promoter with the Moloney murine leukemia virus LTR. Thirty-nine percent (74/186) of all analyzed integrations in RefSeq genes landed in intron sequences (Fig. 3 ). This is a significantly increased proportion compared to the 21% determined as intron sequences in the human genome analysis by Venter et al. [36] . All first introns together make up 5.6% of the human genome [36] . We detected 20% (37/186) of all mapped integrations in the first intron.
These 37 integrations located in the first intron show that integration close to the transcription start site occurs with highly increased probability (Fig. 2) . In contrast to these results it turned out that only 0.5% (1/186) of the analyzed integrations landed in exon sequences that correspond to the percentage determined by Venter and colleagues [36] calculated for all exon sequences of the human genome (1%).
Analysis of Targeted Genes
We further analyzed those 75 integrations that landed in RefSeq genes. The genes were classified into different protein function groups such as signaling factors, transcription factors, kinases, membrane proteins, proteases, and cytoskeleton proteins (Fig. 4) . Groups (e.g., apoptosis factors, regulatory proteins, hormones, ion channels, receptors, translation factors, transporter proteins, growth factors) in which after analysis only two or fewer genes were targeted were combined into a bmiscellaneousQ group. It turned out that 15 integrations were in genes with a signaling function. Six integrations occurred in transcription factors. Detailed results are shown in Fig. 4 .
Through the analysis of the vector integrations it turned out that five genes were targeted multiple times (Table 3) . These are the thyroglobulin gene (NM _ 003235), the phosphodiesterase 4C gene (NM _ 000923), the potassium inwardly-rectifying channel, subfamily J member 16 gene (NM _ 018658), the SET domain, bifurcated 2 gene (NM _ 031915), and the epidermodysplasia verruciformis 1 gene (NM _ 007267). Each of those genes was targeted twice except for the epidermodysplasia verruciformis 1 gene, which had three hits. Interestingly it turned out that in all five cases in which a gene was targeted multiple times the retroviral vector always integrated in the same orientation within the corresponding gene (Table 3) . Statistically 2 5 permutations, i.e., 32 possibilities, of vector orientation in these five genes can occur. The likelihood that all integrations occur in the same orientation by chance is therefore b0.05 (3%), suggesting a significant deterministic effect of the insertion site on the orientation of the provirus.
DISCUSSION
In this study we show that a retroviral vector integrates into the DNA of human peripheral blood progenitor cells (PBPC) with marrow engraftment capability in NOD/ SCID mice with increased frequency in coding regionsespecially in the first intron. The NOD/SCID mouse assay allows us to measure engrafting human hematopoietic cells with short-term repopulating ability when recent comparative data from nonhuman primates are considered [37] . However, long-term clinical gene marking studies with PBPC from normal human donors are not available. Our results with this clinically relevant PBPC target population correspond to recently published studies of cell lines that retroviral vector integrations preferentially occur near the transcription start regions of genes [22, 23] . While it has been shown that 34% of the integrations for MLV and 58% of integrations for HIV landed in RefSeq genes, our data showed that 40% of SF91m3 integrations in human repopulating cells landed in RefSeq genes ( Table 1) . Most of the targeted genes regulate cell proliferation and differentiation, which are essential functions of hematopoietic stem and progenitor cells. We found integrations in 15 genes with signaling function among 186 mapped integration sites, corresponding to a frequency of 8%. Among all human genes (n = 32,000 [36] ) these signaling genes make up for 0.05%. Therefore, our results point to preferred retroviral vector integration in these sites. Since integrations were associated with active gene transcription [22] it may be speculated that the genes with integrations described here give a unique gene expression profile of human primitive hematopoietic cells that cannot be obtained by standard microarray technology since human SRC are too scarce (1:10,000-1:30,000 CD34 + cells [38] ) and too ill defined by immunophenotype. Multiple integrations were found at the same sites, in different clones and different mice and to some extent in different donors, which are the thyroglobulin gene (NM _ 003235), the phosphodiesterase 4C gene (NM _ 000923), the potassium inwardly-rectifying channel, subfamily J member 16 gene (NM _ 018658), the SET domain, bifurcated 2 gene (NM _ 031915), and the epidermodysplasia verruciformis 1 gene (NM _ 007267). Each of these genes was targeted twice except for the epidermo- The chromosomal mapping, corresponding accession number, and targeted gene are shown. Additionally, the RefSeq number of the gene and the exact integration sites on the chromosomes are listed. In the last column the orientation of the provirus within the gene is shown.
FIG. 3.
Graph showing the number of total integrations for the oncoretroviral hybrid vector SF91m3 in the intron sequences of the RefSeq transcripts (n = 75 integrations in RefSeqs).
dysplasia verruciformis 1 gene, which had three hits. In all targeted genes the respective orientations of the provirus within the gene were identical (Table 3 ). In one case the integration occurred exactly at the same site in two independent experiments (EVER1 gene, E3M14, E15M5). All necessary controls were performed during analysis and it is unlikely that this is due to a contamination. In the second case the integration at the identical site occurred within one experiment (C13orf4 gene, E17M17, E17M19). We cannot exclude that the integration occurred in one stem cell that underwent selfrenewal and divided into two daughter cells during transduction, each with repopulating capacity in these separate mice. In all caution these results suggest the existence of steric determinants in the three-dimensional arrangement of the DNA that governs the orientation of proviral integration. Additionally, if the results were compared with integration results obtained by analysis of lentiviral-transduced human cord blood progenitor cells following transplantation and engraftment in immunodeficient mice (pRRLsin, data not shown), common integration sites were detected, such as the early hematopoietic zinc finger (EHZF, NM _ 015461) and the N-acetylated a-linked acidic dipeptidase-like gene (NM _ 005468). It has been shown that EHZF expression is abundant in human CD34 + progenitors and declines rapidly during cytokine-driven differentiation [39] . EHZF has 96% identity to mouse Evi3, a recently identified gene associated with the retroviral integration site in AKXD-27 B-cell lymphomas [40] . Bond and colleagues found significant EHZF mRNA levels in the majority of acute myelogenous leukemias. It has been suggested that EHZF is likely to play a relevant role in the control of human hematopoiesis and might be implicated in the development of hematopoietic malignancies. Our results suggest that highly susceptible acceptor sites for retroviral vectors exist in the human genome that are preferentially expressed in the target cell population.
In the progeny of normal human G-CSF-mobilized PBPC we did not observe a single integration in the LMO2 locus, which was the causative oncogene for the development of leukemia in children in the SCID-X1 trial [23] .
Possible explanations for our findings could be nonrandom vector integration, clonal selection due to gene expression interference, or engraftment issues related to gene insertion in signaling and cell cycle genes. The low frequency of integrations in exons may be reassuring as to the safety of retroviral gene therapy with normal human PBPC.
Further studies can now address factors influencing the distribution of integration sites, which may ultimately lead to the construction of safer retroviral vectors. 
MATERIALS AND METHODS
Selection and retroviral transduction of cells. In this study mobilized peripheral blood CD34 + cells were obtained from five healthy donors after informed consent. CD34 + cells were prepared as described before [41] . Retroviral vector stocks were produced and stored as described [42] . Retroviral transduction was performed as described [40] . In brief, CD34 + cells were prestimulated for 16 to 20 h at a density of 1 Â 10 6 cells/ml X-VIVO-10 medium, supplemented with IL-3 (20 ng/ml), IL-6 (10 ng/ml), SCF (50 ng/ml), FL (100 ng/ml), (CellSystems, St. Katharinen, Germany), and TPO (20 ng/ml) (R&D Systems, Wiesbaden, Germany). Following prestimulation, cells were exposed to retroviral supernatant containing the hybrid vector SF91m3. This vector is based on the Friend mink cell focus-forming/murine embryonic stem-cell virus. It contains the human MDR1 gene under the transcriptional control of the spleen focus-forming virus long-terminal repeat (LTR), which has been combined with a permissive leader sequence of the murine embryonic stem-cell virus to overcome transcriptional repression of U3-mediated gene expression.
NOD/SCID mouse reconstitution assay. Female NOD/LtSz SCID mice were conditioned by sublethal irradiation with a total dose of 3 Gy. Between 3 Â 10 6 and 4 Â 10 6 SF91m3-or mock-transduced human CD34 + cells per mouse were transplanted as described [41, 43] . Mice (n = 21) were killed by cervical dislocation 6-8 weeks posttransplantation. Bone marrow (BM) cells were flushed from the femurs of each mouse into IMDM and engraftment of human cells, as well as presence and expression of the MDR1 transgene, was evaluated as described [41, 43] . Engraftment was measured by quantifying human CD45 antigen-expressing cells. Real-time PCR allowed us to quantify the presence of MDR1 proviral sequences (data not shown). Rhodamine-123 efflux analysis served to detect expression of the MDR1 transgene in engrafting human CD45 + cells. All animal studies were approved by the appropriate authorizing bodies.
Ligation-mediated PCR. For detection of retroviral integration sites, DNA was extracted from 21 NOD/SCID mouse chimeric BM preparations (QiaAmp Blood Kit; Qiagen, Hilden, Germany). LM-PCR was performed as described before [24] . Briefly, isolated BM DNA was digested with restriction enzyme BsmAI or PvuII. Retroviral-human DNA junctions were marked using a biotinylated LTR-specific primer followed by enrichment of the biotin-marked fragments (Dynal). Next, an adapter oligo cassette was blunt-end ligated to the LTR-distant portion of enriched fragments to create binding sites for forward primers. Nested PCR was performed on the purified fragments. PCR products were analyzed on agarose gels, and gel blocks were excised and purified using the Gel Extraction Kit (Qiagen). DNA of each excised gel block was cloned into the pCR4 plasmid vector (Topo TA Cloning Kit; Invitrogen) according to the manufacturer's instructions. Colonies of each cloning reaction were screened for insert length by direct PCR of bacterial colonies with standard vector primers T3 and T7.
Sequence analysis. Cycle sequencing of the plasmids containing LM-PCR amplicon inserts was performed using an ABI Prism Genetic Analyzer 310 (PE Applied Biosystems, Weiterstadt, Germany) according to the manufacturer's instructions.
The sequences were first viewed using Chromas 2.23 software (Technelysium Pty Ltd., Tewantin, Australia). Sequence matches were judged to be authentic only if the matching part of the human query sequence was surrounded by the 5V LTR sequence on the one side and the adapter sequence on the other side. To find identical sequences from different clones within one mouse the sequences were aligned with ClustAl (HUSAR Bioinformatic Group, Heidelberg, Germany) [44] . For sequence analysis the BLAT tool with the UCSC Human Genome Project Working Draft was used (April 2003 freeze, http://genome.ucsc.edu/). The next criterion was that the match to the human genome extended over the length of the high-quality sequence with average identity N97%. The UCSC Genome Browser was used to determine the location of the match with respect to exons and introns. As described before an integration was defined as having landed in a gene only if it was between the transcriptional start and the transcriptional stop boundaries of one of the 20471
